Search for: "Biogen Idec, Inc."
Results 61 - 80
of 113
Sorted by Relevance
|
Sort by Date
29 Jun 2012, 5:00 am
Biogen IDEC, Inc., 2012 WL 2417722, slip op. [read post]
13 Aug 2019, 7:34 pm
” Biogen Idec, Inc. v. [read post]
10 Jun 2010, 3:58 am
(Patent Docs) Avonex (Interferon) – US: Biogen launches submarine patent against competing providers of Interferon-Beta products: Biogen Idec MA Inc. v. [read post]
3 Nov 2011, 12:48 pm
Biogen IDEC, and CyberSource Corp. v. [read post]
6 Sep 2011, 1:10 pm
Biogen IDEC et al. (08-1509). [read post]
12 Nov 2008, 7:00 pm
Biogen IDEC Inc., 537 F.3d 35 (1st Cir. 2008). [read post]
21 Apr 2009, 2:20 pm
We get some insightful additional information from a Dow Jones article, "Biogen Says Sixth MS Patient On Tysabri Gets Brain Infection": Tysabri - sold by the Cambridge, Mass., biotech [Biogen Idec Inc. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog) … [read post]
30 Jun 2014, 11:04 am
Biogen Idec, Inc., 2014 WL 2882104 (W.D.N.Y. [read post]
5 Jul 2010, 11:19 am
Biogen Idec – to the Federal Circuit to reconsider the cases in light of the Bilski decision. [read post]
15 Sep 2010, 8:39 am
Biogen Idec (method of determining an immunization schedule) and Association for Molecular Pathology v. [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development,… [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development,… [read post]
22 Mar 2012, 4:55 am
Biogen Idec, 659 F.3d 1057 (Fed. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term… [read post]
1 Sep 2011, 8:31 am
Biogen Idec. [read post]
1 Sep 2011, 8:31 am
Biogen Idec. [read post]
3 Mar 2017, 7:25 am
Inc. [2007] EWHC 1900 (Pat) and that describing these declarat [read post]
14 Mar 2016, 3:23 am
Never too late 85 [week ending on Sunday 28 February] – AG Yves Bot's take in Reha Training | Battistelli having hard times | Blocking injunctions in trade mark cases | AIPPI UK event | Patent Enforcement Worldwide | Why Mickey Mouse is not mickey mouse | UPC court fees.Never too late 84 [week ending on Sunday 21 February] – Domain Name Law and Practice | Unwired Planet v Huawei and Samsung | In… [read post]
23 Feb 2016, 1:53 am
* English Patent Court speeds up, reminds Mr Justice Carr in Celltrion v BiogenCelltrion Inc. v Biogen Idec Inc., F. [read post]
